ADHD Drugs to Carry Revised Medication Guides for Patients

The Food and Drug Administration sent letters to all manufacturers of medications approved for the treatment of attention-deficit hyperactivity disorder, instructing them to develop patient medication guides within 30 days as a way to notify patients of the possible cardiovascular risks and adverse psychiatric symptoms associated with their use.